New board members from Boehringer Ingelheim, Dechra and Elanco bring deep expertise, bold vision to region’s animal health cluster

One of the most significant economic development projects in Kansas history and the largest to date for Merck Animal Health, the 200,000-square-foot expansion includes an $860 million investment in the site’s existing manufacturing facility and a $35 million investment in its research and development laboratories.

Congratulations to our partners in De Soto, Kansas, on the selection of Merck Animal Health’s announcement to invest $895 million in the expansion of its manufacturing and R&D operations, creating 200 jobs and 200,000-square-feet of new space.

Congratulations to our partners in Overland Park, Kansas, on the selection of the Aspiria Campus for Ceres Tag’s North American headquarters.

The Australian animal health intelligence company revolutionizes animal performance welfare and location monitoring with direct-to-satellite technology

Congratulations to our partners in Elwood, Kansas, on the $130 million investment of Elanco, a global leader in animal health.

Global leader in animal health announced today it plans a $130 million investment through the end of 2026 to expand and renovate its existing manufacturing facility in Elwood, Kansas.

The news that Felixvet, an upcoming manufacturer of generic pharmaceuticals in the companion animal industry, selected the Briarcliff development in Kansas City, Missouri for its North American headquarters garnered industry trade media attention from around the country.

Felixvet, an upcoming manufacturer of generic pharmaceuticals in the companion animal industry, selected Briarcliff for its North American headquarters.

FelixVet cited the region’s pool of top talent, access to the KCI Airport and proximity to their distributor customers throughout the KC Animal Health Corridor.